Latest Financials News

Structural Monitoring Systems Plc (SMS) reported a breakout second half of FY25 with a $3.1 million profit after tax, driven by strong operational leverage and strategic growth in avionics. The company secured over US$1 million in new orders from CAL FIRE and advanced FAA certification for its innovative sensor technology.

Australian Strategic Materials (ASM) reports significant progress in Q2 2025, including its first commercial heavy rare earth metals sale and a transformative low-cost production pathway at its Dubbo Project.

Paladin Energy outlines FY2026 operational ramp-up and financial guidance for its Langer Heinrich Mine, projecting increased uranium production and steady cost control ahead of full-scale operations in FY2027.

Brookside Energy reports robust early production from its ninth horizontal well in the SWISH Play, delivering solid cash flow and promising project economics.

Firebrick Pharma has published positive Phase 3 clinical trial results for its Nasodine nasal spray, showing efficacy against the common cold, while reporting encouraging sales growth in Singapore and the US. However, a recent capital raise fell well short of targets, casting uncertainty over its expansion plans.

Generation Development Group reports a transformative FY25 with record Investment Bond sales and successful integration of Evidentia and Lonsec managed accounts, setting the stage for strong growth in FY26.

Iluka Resources has met its full-year zircon-in-concentrate production guidance by mid-2025 while progressing key projects like Balranald and Eneabba amid ongoing global trade uncertainties.

Magnetic Resources NL’s Feasibility Study confirms a robust standalone development for its Lady Julie Gold Project in Western Australia, projecting over 1 million ounces of gold production across nine years with strong financial returns.

Aurum Resources reports strong high-grade drilling results at its Boundiali and Napié gold projects, backed by a $35.6 million strategic placement to fund resource expansion and feasibility studies.

Invex Therapeutics has broadened its collaboration with Tessara Therapeutics to explore Exenatide’s potential in Alzheimer’s disease, while successfully renewing key orphan drug designations in Europe and the US.

Bastion Minerals and former advisor GTT Ventures have resolved their legal dispute, leading to the withdrawal of a writ that had cast uncertainty over the company.

Spartan Resources Limited shares have been suspended from the ASX following court approval of a scheme of arrangement for its acquisition by Ramelius Resources Limited. This marks a significant step toward the consolidation of gold mining assets in Western Australia.